The longitudinal association between glycaemic control and health-related quality of life following insulin therapy optimisation in type 2 diabetes patients. A prospective observational study in secondary care

Quality of Life Research

Volumn 21, Issue 8, 2012, Pages 1359-1365

  Hajos, T R S ^a   Pouwer, F ^b   De Grooth, R ^c   Holleman, F ^d   Twisk, J W R ^a   Diamant, M ^a   Snoek, F J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TILBURG UNIVERSITY   (Netherlands)

^c Dept of Medical Research   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Emotional well being; Glycaemic control; Insulin glargine; Quality of life; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADAPTIVE BEHAVIOR; ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH STATUS INDICATOR; HUMAN; MALE; MENTAL STRESS; METABOLISM; MIDDLE AGED; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUALITY OF LIFE;

ADAPTATION, PSYCHOLOGICAL; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH STATUS INDICATORS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES; PSYCHOMETRICS; QUALITY OF LIFE; STRESS, PSYCHOLOGICAL;

EID: 84867079276     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-011-0051-0     Document Type: Article

References (30)

1. King, H., Aubert, R. E., & Herman, W. H. (1998). Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care, 21, 1414-1431.
2. Turner, R., Cull, C., & Holman, R. (1996). United Kingdom prospective diabetes study 17: A 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Annals of Internal Medicine, 124, 136-145.
3. U.K. Prospective Diabetes Study Group. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352, 837-853.
4. (2010). Standards of medical care in diabetes-2010. Diabetes Care, 33(Suppl 1), S11-S61.
5. UK Hypoglycaemia Study Group. (2007). Risk of hypoglycaemia in types 1 and 2 diabetes: Effects of treatment modalities and their duration. Diabetologia, 50, 1140-1147.
6. Dluhy, R. G., & McMahon, G. T. (2008). Intensive glycemic control in the ACCORD and ADVANCE trials. The New England Journal of Medicine, 358, 2630-2633.
7. Horvath, K., Jeitler, K., Berghold, A., Ebrahim, S. H., Gratzer, T. W., Plank, J. et al. (2007). Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane database of systematic reviews, 2 Art. no. CD005613.
8. Swinnen, S. G., Dain, M. P., Aronson, R., Davies, M., Gerstein, H. C., Pfeiffer, A. F., et al. (2010). A 24-week, randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs. Diabetes Care, 33, 1176-1178.
9. Lustman, P. J., Anderson, R. J., Freedland, K. E., de, G. M., Carney, R. M., & Clouse, R. E. (2000). Depression and poor glycemic control: A meta-analytic review of the literature. Diabetes Care, 23, 934-942.
10. Rubin, R. R., & Peyrot, M. (1999). Quality of life and diabetes. Diabetes/Metabolism Research and Reviews, 15, 205-218.
11. Lloyd, A., Sawyer, W., & Hopkinson, P. (2001). Impact of longterm complications on quality of life in patients with type 2 diabetes not using insulin. Value Health, 4, 392-400.
12. Gonder-Frederick, L. A., Clarke, W. L., & Cox, D. J. (1997). The emotional, social, and behavioral implications of insulin-induced hypoglycemia. Seminars in Clinical Neuropsychiatry, 2, 57-65.
13. U. K. Prospective Diabetes Study Group. (1999). Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care, 22, 1125-1136.
14. Weinberger, M., Kirkman, M. S., Samsa, G. P., Cowper, P. A., Shortliffe, E. A., Simel, D. L., et al. (1994). The relationship between glycemic control and health-related quality of life in patients with non-insulin-dependent diabetes mellitus. Medical Care, 32, 1173-1181.
15. Van der Does, F. E., De Neeling, J. N., Snoek, F. J., Kostense, P. J., Grootenhuis, P. A., Bouter, L. M., et al. (1996). Symptoms and well-being in relation to glycemic control in type II diabetes. Diabetes Care, 19, 204-210.
16. Testa, M. A., & Simonson, D. C. (1998). Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: A randomized, controlled, double-blind trial. The Journal of the American Medical Association, 280, 1490-1496.
17. Hunt, S. M. (1997). The problem of quality of life. Quality of Life Research, 6, 205-212.
18. Arbuckle, R. A., Humphrey, L., Vardeva, K., Arondekar, B., Danten-Viala, M., Scott, J. A., et al. (2009). Psychometric evaluation of the diabetes symptom checklist-revised (DSC-R) - a measure of symptom distress. Value Health, 12, 1168-1175.
19. Grootenhuis, P. A., Snoek, F. J., Heine, R. J., & Bouter, L. M. (1994). Development of a type 2 diabetes symptom checklist: A measure of symptom severity. Diabet Medicine, 11, 253-261.
20. Cox, D. J., Irvine, A., Gonder-Frederick, L., Nowacek, G., & Butterfield, J. (1987). Fear of hypoglycemia: Quantification, validation, and utilization. Diabetes Care, 10, 617-621.
21. Bech, P., Olsen, L. R., Kjoller, M., & Rasmussen, N. K. (2003). Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 mental health subscale and the WHO-five well-being scale. International Journal of Methods in Psychiatric Research, 12, 85-91.
22. Pouwer, F., & Snoek, F. J. (2001). Association between symptoms of depression and glycaemic control may be unstable across gender. Diabet Medicine, 18, 595-598.
23. Rubin, D. B. (1987). Multiple imputation for nonresponse in surveys. New York: Wiley & Sons.
24. Schafer, J. L., & Graham, J. W. (2002). Missing data: Our view of the state of the art. Psychological Methods, 7, 147-177.
25. de Sonnaville, J. J., Snoek, F. J., Colly, L. P., Deville, W., Wijkel, D., & Heine, R. J. (1998). Well-being and symptoms in relation to insulin therapy in type 2 diabetes. Diabetes Care, 21, 919-924.
26. Arbuckle, R. A., Humphrey, L., Vardeva, K., Arondekar, B., nten-Viala, M. M., Scott, J. A. et al. (2009). Psychometric evaluation of the diabetes symptom Checklist-revised (DSC-R) - a measure of symptom distress. Value Health.
27. DAFNE Study Group. (2002). Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. British Medical Journal, 325, 746.
28. Goldstein, D. E., Little, R. R., Lorenz, R. A., Malone, J. I., Nathan, D., & Peterson, C. M. (1995). Tests of glycemia in diabetes. Diabetes Care, 18, 896-909.
29. Heisler, M., Piette, J. D., Spencer, M., Kieffer, E., & Vijan, S. (2005). The relationship between knowledge of recent HbA1c values and diabetes care understanding and self-management. Diabetes Care, 28, 816-822.
30. Rubin, R. R., & Peyrot, M. (2010). Patient-reported outcomes and diabetes technology: A systematic review of the literature. Pediatric Endocrinology Reviews, 7(Suppl 3), 405-412.